000 00971 a2200301 4500
005 20250517183759.0
264 0 _c20171113
008 201711s 0 0 eng d
022 _a1538-3598
024 7 _a10.1001/jama.2017.14295
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAxelsson, Kristian F
245 0 0 _aAlendronate and Hip Fracture in Patients Using Glucocorticoids-Reply.
_h[electronic resource]
260 _bJAMA
_c11 2017
300 _a1712 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAlendronate
650 0 4 _aBone Density
650 0 4 _aBone Density Conservation Agents
650 0 4 _aGlucocorticoids
650 0 4 _aHip Fractures
650 0 4 _aHumans
650 0 4 _aOsteoporosis, Postmenopausal
700 1 _aNilsson, Anna G
700 1 _aLorentzon, Mattias
773 0 _tJAMA
_gvol. 318
_gno. 17
_gp. 1712
856 4 0 _uhttps://doi.org/10.1001/jama.2017.14295
_zAvailable from publisher's website
999 _c27765705
_d27765705